To determine whether all GMPPB mutations lead to defective neuromuscular transmission and whether the GMPPB-MDDG cases have myasthenic features similar to CMS patients, we performed neurophysiological analysis of GMPPB-MDDG Cases 8–11. This evidence concerns the gene GMPPB and congenital myasthenic syndrome.